Braidwell LP Adaptive Biotechnologies Corp Transaction History

Braidwell LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $1.35 Million - $2.08 Million	389,800 Added 40.28%	1,357,490 $6.65 Billion
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $1.62 Million - $2.69 Million	319,239 Added 49.23%	967,690 $5.27 Billion
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $5.06 Million - $6.56 Million	648,451 New	648,451 $5.73 Billion

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.